Research Achievements
Shinichiro Motohashi| 2012 | 2011 | 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Iwamura C‚ Shinoda K‚ Endo Y‚ Watanabe Y‚ Tumes D.J‚ Motohashi S‚ Kawahara K‚ Kinjo Y‚ Nakayama T. Regulation od memory CD4 T-cell pool size and function by natural killer T cells in vivo.
Proceedings of the National Academy of Sciences of the United States of America. 2012; 109 (42): 16992-16997
Nagato‚ K.‚ Motohashi‚ S.‚ Ishibashi‚ F.‚ Okita‚ K.‚ Yamasaki‚ K.‚ Moriya‚ Y.‚ Hoshino‚ H.‚ Yoshida‚ S.‚ Hanaoka‚ H.‚ Fuji‚ S.‚ Taniguchi‚ M.‚ Yoshino‚ I.‚ and Nakayama‚ T. Accumulation of activated invariant natural killer T cells in the tumor microenvironment after ¦Á-Galactosylceramide-pulsed antigen presenting cells.
Clin.Immunol. 2012; In press
Kuwahara‚ M.‚ Yamashita‚ M.‚ Shinoda‚ K.‚ Tofukuji‚ S.‚ Onodera‚ A.‚ Shinnakasu‚ R.‚ Motohashi‚ S.‚ Hosokawa‚ H.‚ Tumes‚ D.‚ Iwamura‚ C.‚ Lefebvre‚ V.‚ and Nakayama‚ T.: The transcription factor Sox4 is a downstream target of TGF-¦Â signaling and suppresses GATA3-induced TH2 cell differentiation.
Nat. Immunol. 2012; 13 (8): 778-786
Nagai‚ M.‚ Furihata‚ T.‚ Matsumoto‚ S.‚ Ishii‚ S.‚ Motohashi‚ S.‚ Yoshino‚ I.‚ Ugajin‚ M.‚ Miyajima‚ A.‚ Matsumoto‚ S.‚ Chiba‚ K. Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells.
Biochem Biophys Res Commun. 2012; 418 (4): 818-823
Yamashita‚ J.‚ Iwamura‚ C.‚ Mitsumori‚ K.‚ Hosokawa‚ H.‚ Sasaki‚ T.‚ Takahashi‚ M.‚ Tanaka‚ H.‚ Kaneko‚ K.‚ Hanazawa‚ A.‚ Watanabe‚ Y.‚ Shinoda‚ K.‚ Tumes‚ D.‚ Motohashi‚ S.‚ Nakayama‚ T. Murine Schnurri-2 controls Natural Killer cell function and lymphoma development.
Leuk. Lymphoma 2012; 53 (3): 479-486
International Conferences
Taniguchi ‚M.‚ fujii‚ S.‚ Motohashi‚ S.‚ Nakayama‚ T. NKT cell-targeted adjuvant cell therapy-from basic to clinic
14th International Congress of Immunology 2012-8-23 Kobe/Japan
Nagato‚ K.‚Motohashi‚ S. Nakayama‚T. Accumulation of activated invariant NKT cells in the tumor microenvironment after ¦Á-galactosylceramide-pulsed antigen presenting cells.
Clinical Immunology Society (CIS) Annual Meeting 2012-5-17 Chicago/USA
